ライフサイエンスコーパス: benign

1 ared variants is 66.6% in tumor and 91.4% in benign).

2 or triangular shapes and smooth margins were benign.

3 ging to surveillance nodules that are likely benign.

4 (MODY), increase type 2 diabetes risk, or be benign.

5 (78.7%) to be malignant and 46 (21.3%) to be benign.

6 risk of malignancy and can be classified as benign.

7 f all PSMA-positive lesions, were considered benign.

8 6; P < .001), and decreased f(lumen) (PCa vs benign, 0.14 +/- 0.08 vs 0.27 +/- 0.18; P = .004).

9 +/- 0.06; P < .001), decreased f(C) (PCa vs benign, 0.18 +/- 0.06 vs 0.31 +/- 0.13; P = .01), increa

10 n tissues in terms of increased f(A) (PCa vs benign, 0.37 +/- 0.05 vs 0.27 +/- 0.06; P < .001), decre

11 3; P = .01), increased f(epithelium) (PCa vs benign, 0.44 +/- 0.13 vs 0.26 +/- 0.16; P < .001), and d

12 n tumor size was 30 mm, 68.9% (n = 379) were benign, 19.6% (n = 108) borderline, and 10.5% (n = 58) m

13 les, of which 122 (62.5%) were classified as benign, 50 (25.6%) as follicular proliferation, and 7 (3

14 ng 11 of them to be malignant (91.67%) and 1 benign (8.33%).

15 s allowed readers to confidently diagnose as benign a uterine mass demonstrating one or more of these

16 t to find and implement more environmentally benign alternatives.

17 is is a frequent condition, often considered benign, although prior studies have suggested that peric

18 Sixty-two (78%) lesions showed benign and 17 (22%) lesions showed malignant histologic

19 een the curves without early enhancement and benign and borderline lesions as well as between the cur

20 d that only the difference in PC/tCr between benign and cancer lesions was statistically significant

21 gy since HTT171-120Q forms inclusions but is benign and co-expression of HTT171-120Q with non-aggrega

22 10 female subjects with breast masses: five benign and five malignant masses.

23 loic appendagitis (EA) is a relatively rare, benign and local inflammatory disease involving the epip

24 gen (PSMA) uptake has been described in both benign and malignant bone lesions, which can lead to fal

25 of postoperative thrombosis in patients with benign and malignant brain tumors.

26 cular and radiographic imaging appearance of benign and malignant breast lesions on sestamibi scans,

27 teral healthy breast tissue in patients with benign and malignant breast tumors.

28 significant immune suppression of untreated benign and malignant colorectal lesions.

29 lite profiles were distinct in patients with benign and malignant disease.

30 he phosphate and carbonate bands between the benign and malignant groups.

31 Benign and malignant lesions can be identified on planar

32 aps can help radiologists in differentiating benign and malignant lesions depend on the lesion shapes

33 alues showed significant differences between benign and malignant lesions for all 'b' factors (p < 0.

34 ce in DWI signal scores was detected between benign and malignant lesions for all 'b' factors (p < 0.

35 The median SUV(mean) of benign and malignant lesions was 2.3 (interquartile rang

36 Median SUV(max) of benign and malignant lesions was 3.8 (IQR, 3.3-4.5) and

37 Differentiation of benign and malignant lesions was not possible.

38 significant (P < 0.005) differences between benign and malignant lesions were a PSMA RADS rating of

39 background bone SUV(max) Differences between benign and malignant lesions were evaluated for statisti

40 texts: the ability of discriminating between benign and malignant lesions, especially hepatocellular

41 nificantly (P < 0.001) between patients with benign and malignant lesions, with patients with cancer

42 d on the CNN features to distinguish between benign and malignant lesions.

43 FDG PET/MRI biomarkers between patients with benign and malignant lesions.

44 Results revealed that both benign and malignant masses were stiffer than the surrou

45 ' performance in the task of differentiating benign and malignant MRI breast lesions.

46 n variable clinical presentations, including benign and malignant neoplasia and neurodevelopmental di

47 en diverse types of FLLs, especially between benign and malignant ones, is extremely important and ca

48 ffusion coefficient values in discriminating benign and malignant ovarian lesions and might be of fut

49 lue diffusion kurtosis MRI in discriminating benign and malignant ovarian lesions.

50 threshold value for the demarcation between benign and malignant pathologies was computed to be 1.21

51 ter validation, microcalcifications found in benign and malignant samples were correctly recognized w

52 d CNN was capable of differentiating between benign and malignant soft-tissue masses depicted on US i

53 ke and PSMA expression were compared between benign and malignant tissue.

54 ally removed tissue, including non-lesional, benign and malignant tumour.

55 943 solid CP-NCNs, of which 934 (99.0%) were benign and nine (1.0%) were malignant.

56 n of atypical structures usually regarded as benign and often used by medicinal chemists when attempt

57 e breast tissue, exist between patients with benign and patients with malignant breast tumors.

58 tion (LLR) was initially indicated for small benign and peripheral tumors, at present more than half

59 n emergent flavivirus initially considered a benign and self-limited exanthematic illness.

60 nce of the germ line on somatic repair under benign and stressful conditions.

61 at separated known causal MODY variants from benign and type 2 diabetes risk variants and led to recl

62 d of cargo onto serine, generating a stable, benign, and hydrophilic phosphorothioate linkage.

63 ferences in heterogeneity between malignant, benign, and inflamed tissue.

64 are depleting versus renewable, toxic versus benign, and persistent versus readily degradable.

65 ht a promising droplet-based environmentally benign approach to dispersible photosynthetic microbial

66 ifferentiate malignant uterine sarcomas from benign atypical leiomyomas.

67 SUMMARY/BACKGROUND DATA: Benign biliary stricture occurs secondary to bile duct i

68 ology workload by reducing the assessment of benign biopsies and by automating the task of measuring

69 tests, false-positive screening results, and benign biopsy results.

70 ncer based on histopathological examination: benign, borderline, and malignant.

71 nced MRI can be useful for classification as benign, borderline, or malignant because the malignant l

72 Each case was classified as benign, borderline, or malignant.

73 ed in the DVT patients with malignant versus benign brain tumors, atherosclerosis, hypertension, as w

74 e cell motility and invasiveness of TNBC and benign breast epithelial cells.

75 e to biopsy for lesions assessed as probably benign, Breast Imaging Reporting and Data System (BI-RAD

76 sent a management quandary as they are often benign but may also be aggressive TC.

77 ral valve prolapse (MVP) is often considered benign but recent suggestion of an arrhythmic MVP (AMVP)

78 clusion, Xp22.31 duplications appear largely benign, but could slightly increase the likelihood of sp

79 s of uptake that were reliably identified as benign by trained physicians making use of corresponding

80 , access to antiretroviral therapy with more benign cardiovascular disease side effect profiles, indo

81 tilizes Cu(II) acetate as an environmentally benign catalyst in combination with a mild base and proc

82 be classified as pathogenic in comparison to benign classification (OR = 106.15, 95% C.I = 70.66-Inf,

83 findings challenge the notion that pAF is a benign complication.

84 lin function could be an unexpectedly common benign condition in humans that may not require any prot

85 tic methods that can accurately identify the benign condition with certainty.

86 origin of a coronary artery is considered a benign condition.

87 enase achieves this difficult reaction under benign conditions as a means of informing the design of

88 ature variability and never under relatively benign conditions.

89 ence of fetal hemoglobin are both relatively benign conditions.

90 act of avoiding lobectomies in patients with benign core-needle biopsy findings.

91 malignant chRCC from its highly similar but benign counterpart, renal oncocytoma.

92 lignant STTs and distinguish them from their benign counterparts for appropriate management.

93 intestinal disease is associated with a more benign course and lower mortality.

94 bdural hemorrhage (SDH) is thought to have a benign course in asymptomatic neonates.

95 EUS-FNA was also useful to diagnose benign cysts, possibly allowing surveillance to be stopp

96 omatic women with dense breasts had negative/benign DBT examinations before the AB-MR.

97 ications of the bioadhesive with triggerable benign detachment in ex vivo porcine models.

98 tch with tissues, and/or lack of triggerable benign detachment.

99 als for light, flexible, and environmentally benign devices, primarily memories, capacitors, sensors,

100 e value of AB-MR examinations after negative/benign digital breast tomosynthesis (DBT).

101 s with a diagnosis of CD, UC, malignancy, or benign disease (diverticular disease, Clostridium diffic

102 (PSA) levels < 20 ng ml(-1), of whom 31 had benign disease (no cancer) and 41 had prostate cancer.

103 of the global population, causing relatively benign disease in otherwise healthy individuals.

104 s, while 20 participants were excluded for a benign disease, 1 for unavailability of the endoscopist

105 e) were detected in the low-risk patients or benign disease.

106 in patients (including young children) with benign diseases and healthy individuals.

107 ures of various malignant tumor subtypes and benign diseases, either visually or with artificial inte

108 's contact-binary shape was preserved by the benign dynamical and collisional environment of the cold

109 RR, there is an additional strong demand for benign electrochemical reduction of other important heav

110 SCNs of the pancreas are invariably benign entities.

111 anation is that early life care may create a benign environment that offsets inbreeding depression, a

112 h centrotemporal spikes, previously known as Benign Epilepsy with Centro-temporal Spikes (BECTS) or R

113 6-, 12-, and 24-month follow-up of probably benign findings first identified at recall from screenin

114 Transvaginal US results showed benign findings in 95 (64.6%) women and abnormal finding

115 It emphasizes benign findings that can lead to confusion and the crite

116 ch may interfere with survival in relatively benign first primary cancers.

117 ersely, when a halo sign lesion is observed, benign follicular neoplasm should be considered.

118 ng for their exploitation as environmentally benign food packaging material.

119 point defects in beta-CsPbI(3) are generally benign for nonradiative charge recombination, regardless

120 ol to precisely characterize and distinguish benign from malignant breast microcalcifications detecte

121 ule features have been used to differentiate benign from malignant nodules.

122 For the neutral class, this method relied on benign germline variants found in the 1000 Genomes Proje

123 tochemistry revealed strong PSMA staining of benign gland tissue, which impacts measured activities.

124 Often perceived as environmentally benign, 'green' renewable energy technologies have ecolo

125 lid masses in the brain, including cysts and benign growths.

126 ulf and the nearby, but more environmentally benign, Gulf of Oman.

127 ed by a gift donation from Jack Levin to the Benign Hematology programme at Yale, and the National In

128 90 urine specimens: 183 control samples, 208 benign hepatobiliary disease samples (of which 119 were

129 ed by means of the use of an environmentally benign HFIP-UHP system.

130 Further 33 had advanced disease, 30 benign histology.

131 The development of environmentally benign hydrometallurgical processes to treat spent lithi

132 ns that were falsely interpreted as probably benign in PET-1 (P = 0.023).

133 1 lesions with outcomes (28 malignant and 53 benign) in 67 women (median age, 49 years; interquartile

134 For two variants that were predicted to be benign, in vitro modeling demonstrated that these mutati

135 This benign increase in contractility may benefit patients ad

136 elative to 534 subjects with asymptomatic or benign infection.

137 s, and tumours are now further subdivided as benign, intermediate (locally aggressive or rarely metas

138 subcategory; STTs are further subdivided as benign, intermediate (locally aggressive or rarely metas

139 more effective, or at the very minimum, more benign interventions for implementation.

140 asymptomatic hyperuricaemia was considered a benign laboratory finding with little clinical importanc

141 enhance ferroelectricity in environmentally benign lead-free oxides, which hold great promise for ap

142 ificantly lower in malignant lesions than in benign lesions (0.17 vs. 0.70, P = 0.02).

143 differed significantly between patients with benign lesions (mean, 1.9) and patients with malignant l

144 significant difference between malignant and benign lesions (P < .001).

145 um(2)/msec), and 0.65 (range, 0.44-1.43) for benign lesions (P values of .01, .02, < .001, respective

146 IPLNs are benign lesions and do not require follow-up after initia

147 The benign lesions most frequently observed were ganglia, un

148 nant lesions showed a greater mean size than benign lesions regardless of the group (P = 0.015).

149 th early disease (i.e., lower proportions in benign lesions than in more severe lesions), whereas sma

150 ), and K(app) to discriminate malignant from benign lesions was calculated, as was specificity at a s

151 s coefficient (K(app)) between malignant and benign lesions were assessed by using a logistic mixed m

152 (55.14%) lesions, and in 256 (43.17%) cases benign lesions were confirmed by histopathological exami

153 ibility and differentiation of malignant and benign lesions within the breast.Materials and Methods:

154 nography result, although 81.0% of them were benign lesions, and the other 19.0% needed follow-up or

155 gen-presenting cells was limited compared to benign lesions, suggesting that primary and metastatic h

156 ignant, 8 pre-malignant, and the remaining 4 benign lesions.

157 ate a CNN model to distinguish malignant and benign lesions.

158 vessels and retinal cavernous hemangioma are benign lesions.

159 Results: There were 100 malignant and 41 benign lesions.

160 ecimens correspond to adenomas or even other benign lesions.

161 ent schemes in a variety of almost certainly benign lesions.

162 task of distinguishing between malignant and benign lesions.

163 redictor (p = 0.044) of a histologically non-benign lipoma.

164 ound Hepatocellular adenomas (HCAs) are rare benign liver tumors.

165 The model trained to classify malignant and benign masses demonstrated an accuracy of 79% (95% CI: 6

166 erformance of the model distinguishing three benign masses was lower, with an accuracy of 71% (95% CI

167 the 419 patients containing the three common benign masses was used to train and evaluate a separate

168 in silico platform to attempt to distinguish benign MEK mutations from those that are functional and,

169 tially expressed in melanomas as compared to benign melanocytic lesions, a limited consensus has been

170 ssion was elevated in melanoma compared with benign melanocytic lesions.

171 Conversely, our data show that benign meningiomas (MENs), which contain less water than

172 d growth rates of ten spinal and ten cranial benign meningiomas in seven NF2 patients that concluded

173 ruptive Spitz nevus is a striking example of benign metastasis, demonstrating that metastasis can occ

174 er evaporation represents an environmentally benign method of water purification/desalination.

175 ecifically emerged as marker of benignity in benign microcalcifications.

176 s, p53 and myoglobin, and for pathogenic and benign missense variants from ClinVar.

177 set of clinically interpreted pathogenic and benign missense variants.

178 scriminate between pathogenic and putatively benign missense variants.

179 nificantly upregulated in cancer relative to benign mucosa.

180 2-0.996) on the external validation dataset (benign n=108, malignant n=222).

181 variants were initially classified as likely benign (n = 2), likely pathogenic (n = 10), or VUSs (n =

182 iopsy specimens determined the lesions to be benign (n = 55), invasive ductal carcinoma (n = 51), inv

183 Variants were classified as benign (n=1702), likely benign (n=33), uncertain signifi

184 s were classified as benign (n=1702), likely benign (n=33), uncertain significance (n=71), likely pat

185 % CI 0.994-0.999) for distinguishing between benign (n=910) and malignant (n=721) biopsy cores on the

186 lifetime scanning confirm the electronically benign nature of the twin boundaries, in striking contra

187 .4%) benign nonneoplastic results, 10 (6.8%) benign neoplasms, five (3.4%) malignant neoplasms, and t

188 Plexiform neurofibromas are benign nerve sheath Schwann cell tumors characterized by

189 to-oncogene in melanocytes reliably produces benign nevi (pigmented 'moles'), yet the same change is

190 Twenty-five patients had benign nodular lesions.

191 ns in the validation cohorts for cancers and benign nodules compared with the Mayo model were 0.34 (V

192 able and accurate identification of IPLNs as benign nodules may substantially reduce the number of un

193 tegories in more than a third of cancers and benign nodules when compared with conventional risk mode

194 of 139 HCCs, 18 non-HCC malignancies, and 39 benign nodules) was performed in a three-reader blinded

195 122 HCCs, 18 non-HCC malignancies, and three benign nodules).

196 ules that require surgery, and 98.6% NPV for benign nodules.

197 costs of diagnosis compared to lobectomy in benign nodules.

198 tiation of HCC from non-HCC malignancies and benign nodules.

199 Histopathologic reports showed 130 (88.4%) benign nonneoplastic results, 10 (6.8%) benign neoplasms

200 tive of prostate cancer from those that were benign, on the basis of known pitfalls and ancillary inf

201 ng minimally invasive to OPD for adults with benign or malignant disease requiring elective pancreati

202 bral marrow lesions can be differentiated as benign or malignant with good sensitivity and specificit

203 s, radiologists must determine whether it is benign or malignant, and if it is malignant, what subtyp

204 mmographically occult breast lesions, either benign or malignant, could be detected by ultrasound in

205 genuine or counterfeit or a tissue sample is benign or malignant.

206 d for the final interpretation of lesions as benign or malignant.

207 tated genotypic data to classify variants as benign or pathogenic based on our functional scores.

208 e differentiate a sequence variant as either benign or pathogenic, such that the appropriate therapeu

209 BEC3-induced mutations are more likely to be benign or subsequently clear, suggesting they may reduce

210 increased PSMA-ligand uptake attributed to a benign origin is considerably higher for (18)F-PSMA-1007

211 differentiated from lesions attributed to a benign origin on the basis of known pitfalls and informa

212 imately 5 times more lesions attributed to a benign origin than did (68)Ga-PSMA-11 PET (245 vs. 52 le

213 The SUV(max) of lesions attributed to a benign origin was significantly higher (P < 0.0001) for

214 is the most common cause of pseudoachalasia, benign origins have also been described.

215 R complex rapidly, and then to dissolve into benign orthosilicic acid, makes them an appealing option

216 with Langerhans Cell Histiocytosis (LCH), a benign osteolytic tumor-like disorder involving mainly t

217 s that overparameterization is essential for benign overfitting in this setting: the number of direct

218 The phenomenon of benign overfitting is one of the key mysteries uncovered

219 d is dysregulated in human disorders such as benign overgrowth syndromes, cancer, primary immune defi

220 aqueous medium using hydrogen peroxide as a benign oxidant and ammonium thiocyanate as a thiocyanati

221 ch as the use of air that is considered as a benign oxidant and EtOH as a green solvent, ease of prod

222 d purifying phases, and the use of O(2) as a benign oxidant, in addition to being scalable and having

223 alectin-9 was able to discriminate PDAC from benign pancreatic disease and healthy individuals, and w

224 nesis protocol potentiated the conversion of benign papillomas to carcinomas by elevating p38MAPK and

225 The mean ADC value of benign pathologies was significantly greater than malign

226 onstrated imaging characteristics of lipoma, benign peripheral nerve sheath tumor, and vascular malfo

227 operates in pure and untreated sea water at benign pH (2-8) and ambient temperature and pressure.

228 Drivers of sporadic benign pituitary adenoma growth are largely unknown.

229 raffin embedded melanomas and their adjacent benign precursor nevi.

230 tions that are attractive as environmentally benign processes-with excellent product yields and stere

231 patial scales, with relatively warm and wet (benign, productive) regions supporting greater numbers o

232 rames, ultimately bioresorbing harmlessly to benign products without residues, to eliminate the need

233 model, distinguished between the presence of benign prostate disease and prostate cancer.

234 ack of specificity to differentiate PCa from benign prostate disorders stimulates the search for alte

235 tors, are widely used antiandrogen drugs for benign prostate hyperplasia.

236 h PCa and normal individuals with or without benign prostatic disease.

237 tween periodontitis and prostate diseases of benign prostatic hyperplasia (BPH) and prostatitis is un

238 Benign prostatic hyperplasia (BPH), a nonmalignant enlar

239 -induced myopathic bladder dysfunction (from benign prostatic hyperplasia or posterior urethral valve

240 with prostatic artery embolization (PAE) for benign prostatic hyperplasia remains limited.

241 ation was a safe and effective procedure for benign prostatic hyperplasia with good long-term results

242 une 2018 in patients with moderate to severe benign prostatic hyperplasia-related symptoms.

243 t symptoms or urinary retention secondary to benign prostatic obstruction were randomly assigned (1:1

244 t symptoms or urinary retention secondary to benign prostatic obstruction.

245 rostate (TURP) is the standard operation for benign prostatic obstruction.

246 echanism that underlies the ability of these benign proteins to become allergens.

247 est narrower margins are sufficient, and for benign PT, a negative margin may not be necessary.

248 commend re-excision of a negative margin for benign PT, regardless of margin width, as a progressivel

249 ents have higher relative densities and more benign radiation fields than in stellar ejectae or the d

250 sion in malignant renal tumors compared with benign renal masses, supporting further assessment of DP

251 Patients with the most common benign renal tumor, renal oncocytomas, may be overtreate

252 neous sampling, and 38 of 38 (100%) revealed benign results.

253 ss substituted crystal lattice compared with benign samples.

254 network to differentiate disease-causing and benign SAVs based on a variety of protein sequence, stru

255 Benign selection agents serve as alternatives to antibio

256 In contrast, benign selection markers complement GMOs with reduced fi

257 In this pathway, benign sensations from the gut induce maladaptive cognit

258 Pilomatricoma, a benign skin appendage tumor, also known as calcifying ep

259 Dermatofibromas are common benign skin lesions, the etiology of which is poorly und

260 or folliculin (FLCN) and is characterized by benign skin tumours, lung and kidney cysts and renal cel

261 Human insulinomas are rare, benign, slowly proliferating, insulin-producing beta cel

262 s that catalyse nitric oxide generation from benign sodium nitrite in the presence of modest electric

263 t reaction time, water as an environmentally benign solvent, and the synthesis of vitamin B(12) compo

264 e ongoing efforts to develop environmentally benign sources of energy and to advance technologies for

265 This environmentally benign synthetic protocol employing an inexpensive catal

266 oducts are considered a more sustainable and benign technology.

267 is at baseline, but it was nevertheless more benign than previous estimates from tertiary centers.

268 Benign thyroid disorders, especially hyper- and hypothyr

269 Benign thyroid mesenchymal tumours have excellent progno

270 thyroid function and growth of malignant and benign thyroid tumors.

271 IDC-P from PC, as well as PC and IDC-P from benign tissue on formalin-fixed paraffin-embedded first-

272 ated; 20 regions from 17 PCas, along with 20 benign tissue regions of interest, were analyzed.

273 - 8%, respectively, to differentiate PC from benign tissue, and 95% +/- 2%, 96% +/- 4%, and 94% +/- 2

274 n the prostate and differ between cancer and benign tissue.

275 the prostate base, with PC cells overlaid by benign tissue.

276 Differences between PCa and benign tissues in terms of DR-CSI signal components and

277 PCa exhibited differences compared with benign tissues in terms of increased f(A) (PCa vs benign

278 uctural dependence patterns are sufficiently benign to allow the derivation of robust functional anat

279 ected the transition from the control stage (benign) to the early stage of hepatocellular carcinoma o

280 history of tumors, those with a history of a benign tumor (nonmalignant tumor with functional impairm

281 emonstration of widespread distribution of a benign tumor with limited proliferative capability indic

282 MI displacement (1.1 +/- 0.5 um) compared to benign tumors (3.6 +/- 1.5 um) and the adjacent non-canc

283 ogeneous group of tumors that encompass both benign tumors cured with surgical resection and highly l

284 antile hemangiomas (IHs) are the most common benign tumors in early childhood.

285 to malignant tumors versus those arising in benign tumors or shared with normal tissues.

286 Although a history of benign tumors was not associated with an increased ESKD

287 ch as HPV-11, which cause the development of benign tumors, interacts with the cellular E3 ubiquitin

288 zed extracellular matrix, resulting in rigid benign tumors.

289 ients with distinct OvC types and one with a benign tumour, were cultured for 30 days in agitation-ba

290 Studies reporting treatment of benign tumours, extraocular tumours, or other forms of s

291 and a markedly hypoechoic solid nodule; and benign ultrasonographic features, such as predominantly

292 UTI are heterogeneous and range from rather benign, uncomplicated infections to complicated UTIs (cU

293 ncer cells, but not in the less glycosylated benign urothelial cells.

294 predictors in distinguishing pathogenic from benign variants.

295 red in protein 3-dimensional structures than benign variants.

296 Retinal astrocytic hamartomas (RAH) is a benign vascularized glial tumor of the retina.

297 s activatable by biologically and chemically benign visible and near-infrared (NIR) light.

298 Course and prognosis are benign, visual acuity usually recovers.

299 agents with the formation of environmentally benign water as a byproduct.

300 The present approach is environmentally benign, which liberates water as the sole byproduct.